Passage Bio, Inc.
PASG
$7.47
-$0.07-0.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.52M | 6.09M | 4.71M | 7.25M | 6.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.33M | 13.82M | 14.27M | 15.91M | 16.94M |
| Operating Income | -10.33M | -13.82M | -14.27M | -15.91M | -16.94M |
| Income Before Tax | -9.39M | -15.41M | -12.73M | -19.34M | -15.99M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.39M | -15.41M | -12.73M | -19.34M | -15.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.39M | -15.41M | -12.73M | -19.34M | -15.99M |
| EBIT | -10.33M | -13.82M | -14.27M | -15.91M | -16.94M |
| EBITDA | -10.17M | -13.62M | -13.55M | -15.15M | -16.14M |
| EPS Basic | -2.96 | -4.96 | -4.11 | -6.26 | -5.09 |
| Normalized Basic EPS | -1.85 | -2.57 | -2.57 | -2.94 | -3.09 |
| EPS Diluted | -2.96 | -4.96 | -4.11 | -6.26 | -5.09 |
| Normalized Diluted EPS | -1.85 | -2.57 | -2.57 | -2.94 | -3.09 |
| Average Basic Shares Outstanding | 3.17M | 3.11M | 3.09M | 3.09M | 3.14M |
| Average Diluted Shares Outstanding | 3.17M | 3.11M | 3.09M | 3.09M | 3.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |